August 11/2015 Top StoryPlugging the China Industry Knowledge Gap Despite its sheer size, China’s $60+ billion medicines market remains a work in progress. Change is the dominant strategic and operational theme; it’s a “paint as you go” canvas whose color fields are only gradually being filled in. The Tufts Center for the Study of Drug Development aims to plug the knowledge gap at the lower end of China’s trade business through a new partnership .../ Read more / |
||||||||
| sponsored PPD real-time data & analytics platform to advance clinical trials. |
||||||||
| Event Alzheimer’s Update: What to Make of the Latest Buzz Alzheimer’s disease (AD) researchers have seen more than their share of hopefulness and disillusionment over the years. And to follow the news coming out of July’s Alzheimer’s Association International Conference in Washington, writes Casey McDonald, one had to be prepared for both glass half-full and half-empty interpretations .../ Read more / |
||||||||
| Adherence Adherence is no longer. The emphasis is now on patient activation, but how significant will this change be? How can drugmakers become more collaborative in engaging and empowering patients? Mobile tech and data ownership will certainly play a key role ... / Read more / |
||||||||
| Europe Greece: More Than Next Week’s Medicines Supply at Risk There are some evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges, which may, over time, prove to be more difficult for the industry to cope with .../ Read more / |
||||||||
| Leadership Pharm Exec’s Emerging Pharma Leaders 2015 This year’s group of Emerging Pharma Leaders adds to a list of more than 200 alumni dating back to June 2008. We called that first cohort of leaders “the change generation” and frankly the description remains apt today. What is different is a greater diversity in leader backgrounds and the skills required to advance to the “c-suite” .../ Click here for the slide show / |
||||||||
industry update
|
 |
|
 |
|
|
|
 |
 |
 |
 |
 |
 |